Biological activity of IL 23 and IL 17
Biological activity of IL 23 and IL 17
Biological activity of IL 23 and IL 17
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
References<br />
• Yoichiro Iwakura <strong>and</strong> Harumichi Ishigame, 2006, <strong>IL</strong>-<strong>23</strong>/<strong>IL</strong>-<strong>17</strong> axis in inflammation, jci, 116<br />
• Frucht DM. <strong>IL</strong>-<strong>23</strong>: a cytokine that acts on memory T cells. Sci STKE 2002;2002:PE1.<br />
• Lankford CS <strong>and</strong> Frucht DM. A unique role for <strong>IL</strong>-<strong>23</strong> in promoting cellular immunity. J Leukoc Biol 2003;73:49–56.<br />
• Langowski, J. L. et al., <strong>IL</strong>-<strong>23</strong> promotes tumour incidence <strong>and</strong> growth. Nature, 2006. 442: 461–465.<br />
• Chia-Hui Lo et al., 2003. Antitumor <strong>and</strong> antimetastatic <strong>activity</strong> <strong>of</strong> <strong>IL</strong>-<strong>23</strong>. J. Immunol. <strong>17</strong>1:600–607.<br />
• Jing-Sheng Hao <strong>and</strong> Bao-En Shan, 2006, Immune enhancement <strong>and</strong> anti-tumor <strong>activity</strong> <strong>of</strong> <strong>IL</strong>-<strong>23</strong>, Cancer Immunol<br />
Immunother, 55: 1426-143<br />
• David C. Wraith, Anti-cytokine vaccines <strong>and</strong> immunotherapy <strong>of</strong> autoimmune diseases, Eur. J. Immunol. 2006. 36: 2844–2848<br />
• Sarah L Gaffen, Biology <strong>of</strong> recently discovered cytokines: Interleukin-<strong>17</strong> – a unique inflammatory cytokine with roles in bone<br />
biology <strong>and</strong> arthritis, Arthritis Res Ther 2004, 6:240-247<br />
• Kawaguchi M et al., <strong>IL</strong>-<strong>17</strong> cytokine family. J Allergy Clin Immunol 2004;114:1265-73<br />
• M I Koenders et al., Potential new target in arthritis therapy:interleukin (<strong>IL</strong>)-<strong>17</strong> <strong>and</strong> its relation to tumour necrosis factor <strong>and</strong><br />
<strong>IL</strong>-1 in experimental arthritis , Ann Rheum Dis 2006;65;29-3<br />
• Watford, W. T., et al. 2004. Signaling by <strong>IL</strong>-12 <strong>and</strong> <strong>IL</strong>-<strong>23</strong> <strong>and</strong> the immunoregulatory roles <strong>of</strong> STAT4. Immunol. Rev. 202: 139–<br />
156.<br />
• Lankford, C. S. R. <strong>and</strong> Frucht, D. M., A unique role for <strong>IL</strong>-<strong>23</strong> in promoting cellular immunity. J. Leukoc. Biol. 2003. 73: 49–56.<br />
• Sonderegger, I. et al., Neutralization <strong>of</strong> <strong>IL</strong>-<strong>17</strong> by active vaccination inhibits <strong>IL</strong>-<strong>23</strong>-mediated autoimmune myocarditis. Eur. J.<br />
Immunol. 2006. 36: DOI: 10.1002/eji.200636484<br />
• Rhn, T. A. et al., Vaccination against <strong>IL</strong> <strong>17</strong> suppresses autoimmune arthritis <strong>and</strong> encephalomyelitis Eur. J. Immunol. 2006. 36:<br />
DOI: 10.1002/eji.200636658<br />
• Uyttenhove, C. <strong>and</strong> Van Snick, J., Development <strong>of</strong> an anti-<strong>IL</strong> <strong>17</strong>A autovaccine that prevents experimental auto-immune<br />
encephalomyelitis Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636662<br />
• Numasaki, M. et al. Interleukin-<strong>17</strong> promotes angiogenesis <strong>and</strong> tumor growth. Blood 101, 2620–-2627 (2003).<br />
• Lubberts, E., M. I. Koenders, <strong>and</strong> W. B. van den Berg. 2005. The role <strong>of</strong> T cell interleukin-<strong>17</strong> in conducting destructive<br />
arthritis: lessons from animal models. Arthritis Res. Ther. 7: 29–37.
Change language